← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
76	76 Lunai Bioworks LNAI $4.05M	43	-1	-2%	$21.5M
77	77 Opus Genetics IRD $337M	41	+1	+3%	$6.69M
78	SIOX 78 DELISTED Sio Gene Therapies Inc. Common Stock SIOX	41	-7	-15%	$12.2M
79	79 Calidi Biotherapeutics CLDI $2.25M	40	+13	+48%	$202M
80	80 DELISTED BRAINSTORM CELL THERAPUTC BCLI	39	-4	-9%	$15.3M
81	DBTX 81 DELISTED Decibel Therapeutics, Inc. Common Stock DBTX	39	-1	-3%	$53.8M
82	82 Celularity CELU $43.2M	38	+14	+58%	$232M
83	83 Pluri PLUR $11.9M	38	-9	-19%	$4.32M
84	84 Mesoblast MESO $1.81B	37	-5	-12%	$13.1M
85	GRCL 85 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	34	-1	-3%	$75.1M
86	86 INmune Bio INMB $45.8M	34	-9	-21%	$19.1M
87	BLCM 87 DELISTED Bellicum Pharmaceuticals, Inc. BLCM	29	+5	+21%	$3.76M
88	88 Capricor Therapeutics CAPR $423M	29	+4	+16%	$8.95M
89	89 DELISTED Scorpius Holdings, Inc. SCPX	29	-4	-12%	$8.22M
90	ONCS 90 DELISTED OncoSec Medical Incorporated ONCS	28	-6	-18%	$6.09M
91	ACHL 91 DELISTED Achilles Therapeutics ACHL	25	-5	-17%	$101M
92	92 Enlivex Ltd ENLV $4.46M	25	+2	+9%	$4.75M
93	93 MiNK Therapeutics INKT $50.7M	25	+4	+19%	$1.76M
94	94 PharmaCyte Biotech PMCB $3.84M	25	-1	-4%	$8.83M
95	95 TScan Therapeutics TCRX $16.2M	25	-4	-14%	$26.3M
96	96 BioCardia BCDA $14.2M	24	+1	+4%	$5.49M
97	RCOR 97 DELISTED Renovacor, Inc. RCOR	24	+1	+4%	$33.8M
98	98 Candel Therapeutics CADL $682M	23	+3	+15%	$34M
99	99 Imunon IMNN $5.95M	23	-14	-38%	$2.66M
100	100 DELISTED Orgenesis Inc. Common Stock ORGS	22	-4	-15%	$5.67M